Severe post-transplant lymphoproliferative disorder after living donor liver transplantation

Kaori Kuramitsu, Takumi Fukumoto, Kenji Fukushima, Takeshi Iwasaki, Masahiro Tominaga, Toshimitsu Matsui, Fumi Kawakami, Tomoo Itoh, Yonson Ku

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Post-transplant lymphoproliferative disorder (PTLD) is a well-known complication after transplantation. A living donor liver transplantation was performed on a 31-year-old man for fulminant hepatitis. He again developed liver dysfunction after 7months. He was diagnosed as having acute cellular rejection and the steroid pulse therapy introduced resulted in little improvement. He gradually developed a high fever and right axillary lymphadenopathy appeared. Chest computed tomography (CT) was performed revealing small lung nodules and axillary lymphadenopathy. Because his serological status for Epstein-Barr virus was positive, PTLD was highly suspected and immunosuppression treatment was withdrawn with little improvement. One week later, he developed tachycardia. Chest CT was re-performed revealing an infiltration to the left cardiac chamber. For diagnosis, axillary lymph node biopsy was performed and during the procedure, he developed ventricular tachycardia (VT). Immunohistological staining revealed PTLD of T lymphocytes, and chemotherapy was introduced on the same day he developed VT. After two cycles of tetrahydropyranyl, adriamycin, cyclophosphamide, vincristine, prednisolone and etoposide treatment, he completely recovered. This is a first case report of severe PTLD with VT, and our case implies the feasibility of chemotherapy after the appearance of dissemination symptoms.

Original languageEnglish
Pages (from-to)356-362
Number of pages7
JournalHepatology Research
Volume45
Issue number3
DOIs
StatePublished - 1 Mar 2015
Externally publishedYes

Keywords

  • Chemotherapy
  • Epstein-Barr virus
  • Liver transplantation
  • Post-transplant lymphoproliferative disorder

Fingerprint

Dive into the research topics of 'Severe post-transplant lymphoproliferative disorder after living donor liver transplantation'. Together they form a unique fingerprint.

Cite this